Humpath.com - Human pathology

Home > D. General pathology > Therapy, Toxics and drugs > BCR-ABL inhibitors

BCR-ABL inhibitors

Sunday 20 January 2008

Reviews

- Schiffer CA. BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia. N Engl J Med. 2007 Jul 19;357(3):258-65. PMID: 17634461

- Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, Griffin JD. Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia. Nat Rev Cancer. 2007 May;7(5):345-56. PMID: 17457302

- O’hare T, Corbin AS, Druker BJ. Targeted CML therapy: controlling drug resistance, seeking cure. Curr Opin Genet Dev. 2006 Feb;16(1):92-9. PMID: 16343892

- Giles FJ, Cortes JE, Kantarjian HM. Targeting the Kinase Activity of the BCR-ABL Fusion Protein in Patients with Chronic Myeloid Leukemia. Curr Mol Med. 2005 Nov;5(7):615-23. PMID: 16305488